We evaluated the diagnostic performance of a genomic DNA amplification method for Bordetella pertussis and Bordetella parapertussis compared with culture isolation. Aliquots from B. pertussis and B. parapertussis cultures were added to sterile physiological saline or sterile distilled water to give bacterial suspensions of 10 8 cells/ml and serial dilutions were prepared. Suspensions in physiological saline were cultured on charcoal agar medium; bacterial growth was observed up to dilutions of 10 -7 . Suspensions in distilled water were subjected to DNA extraction and nested polymerase chain reaction (PCR) was performed on the extracts; the PCR was positive up to dilutions of 10 -8 for B. pertussis and 10 -9 for B. parapertussis. Since the efficacy of culture isolation, regarded as the standard for the detection of B. pertussis and B. parapertussis, declines after the first stage of pertussis or with prior vaccination or antibiotic therapy, PCR, although not yet standardized, may provide an alternative diagnostic tool.
Introduction
Pertussis is one of the most important vaccine-preventable paediatric diseases, because of the large number of cases and the associated risks of serious complications, such as pneumonia and fatal encephalopathy. Pertussis occurs worldwide with endemic/epidemic activity. Epidemics recur every 3 -5 years, with a summer-autumn seasonal pattern. 1 Infection is transmitted by infected individuals; the existence of a silent carrier state has not been demonstrated. 2 The principal aetiological agent is Bordetella Comparison of PCR and culture for detection of B. pertussis and B. parapertussis pertussis, but similar clinical pictures can be attributed to other bordetellas, such as Bordetella parapertussis.
The important epidemiological impact of this infection led to the search for an effective vaccine. A whole-cell vaccine was the first to be developed more than 50 years ago and was given in conjunction with tetanus and diphtheria toxoids (DTP vaccine). More recently, more than 20 different acellular vaccines have been developed that have replaced the whole-cell vaccine; only some of these have been tested in controlled clinical trials. In Italy, the primary vaccination series consists of three doses during the first year of life (at 3, 5 and 11 -12 months), followed by a booster dose at 5 -6 years. 3 Epidemiological data demonstrate that pertussis has remained endemic in countries with low vaccination coverage, with incidence peaking in children < 7 years. In contrast, in countries with high pertussis vaccination coverage rates the distribution of cases has changed, with an increase in older children, adolescents and adults. 4 -6 Epidemiological studies in Italy have shown that, although the total incidence of pertussis has markedly dropped, the incidence in those aged 5 -9 years and 10 -14 years has increased, and the average age of occurrence has also increased. 3 As has occurred in the countries that first achieved high pertussis vaccination coverage, incidence rates are also expected to increase among adolescents and young adults, who will then become a reservoir for the infection and a source of transmission of B. pertussis.
Within this context, accurate direct diagnosis is crucial. The aim of this study was to evaluate the diagnostic performance of a genomic DNA amplification method for B. pertussis and B. parapertussis compared with the standard test of culture isolation.
Materials and methods

BACTERIAL CULTURES
Bacterial cultures were obtained using standard strains of B. pertussis (American Type Culture Collection 9340) and B. parapertussis (American Type Culture Collection 15237), bought in the form of BACTi ™ disks (Remel Ltd, Lenexa, Kansas, USA). The Bordetella species were cultured on charcoal agar medium containing 10% v/v horse blood and 40 g/ml of cephalexin, a contaminant inhibitor that allows a greater number of isolations of viable B. pertussis and B. parapertussis.
The plates were incubated at 35°C in a humid atmosphere (60 -70%) for 6 days. They were checked after the first 40 h of incubation and subsequently twice a day. Any plates on which growth was observed were considered to be positive, regardless of the number of colonies.
PREPARATION OF SAMPLES
Aliquots of the B. pertussis and B. parapertussis cultures were transferred into test tubes containing sterile physiological saline (9 g NaCl/l sterile distilled water) or sterile distilled water. The number of cells in each test tube was sufficient to obtain a bacterial suspension equal to the 0.5 McFarland turbidity standard (approximately 10 8 cells/ml).
For both test suspensions, serial dilutions were prepared (10 -1 , 10 -2 , 10 -3 , 10 -4 , 10 -5 , 10 -6 , 10 -7 , 10 -8 and 10 -9 ). All experiments were performed in triplicate.
CULTURE
Aliquots (l ml) of the bacterial suspensions of B. pertussis and B. parapertussis in sterile physiological saline and their serial dilutions were placed onto charcoal agar plates and incubated at 35°C for 6 -7 days. The bacterial suspensions in sterile distilled water were not cultured because the bacterial cells, being in a hypotonic solution, would Comparison of PCR and culture for detection of B. pertussis and B. parapertussis be exposed to high osmotic stress and would consequently not be viable or culturable.
DNA EXTRACTION
Aliquots (2 ml) of both types of bacterial suspension of B. pertussis and B. parapertussis and their serial dilutions were subjected to DNA extraction using the QIAamp ™ DNA Blood Mini Kit (Qiagen, Hilden, Germany). The aliquots were centrifuged at 5000 g for 20 min; the supernatant was removed and the precipitant resuspended in 180 ml of ATL buffer (a lysis buffer). Then 20 ml of proteinase K was added and the samples were incubated at 56°C for 50 min. Next, 200 µl of AL buffer (a lysis buffer) was added, the samples were vortexed and incubated at 70°C for 10 min, and 200 µl of ethanol (96 -100%) was added. The mix was transferred onto a 2 ml QIAamp ™ spin column and centrifuged at 6000 g for 1 min. Then 500 ml of AW1 buffer (a washing buffer) was added and the tube was centrifuged at 6000 g for 1 min. The column was then removed from the centrifuge and the sample placed into a new collection tube together with 500 ml of AW2 buffer (a washing buffer); this was then centrifuged at maximum speed (20 000 g) for 3 min. Finally, 200 µl of AE buffer (an elution buffer) was added and the sample centrifuged at 6000 g for 1 min.
The concentration of extracted DNA was determined spectrophotometrically using the following formula:
where A 260nm is the absorbance at 260 nm, Cf is the correction factor and Df is the dilution factor.
The DNA yield was calculated by multiplying the DNA concentration by the final volume derived from the extraction.
The purity of the DNA solution was estimated from the ratio of the absorbance at 260 nm and 280 nm (A 260 /A 280 ); the optimal range for this ratio is 1.7 -1.9.
NESTED POLYMERASE CHAIN REACTION
Genomic DNA was assessed using the polymerase chain reaction (PCR) with the repeated insertion sequences IS481 and IS1001 for B. pertussis and B. parapertussis, respectively, as the target regions. Briefly, 10 ml of the DNA extract was added to a 40 ml mix containing 5 ml of PCR buffer × 10 (without MgCl 2 ), 2.4 ml of 25 mM MgCl 2 , 1.6 ml of 5 mM deoxynucleotide triphosphate (dNTP) mix, 1 ml of each of the two outer primers (100 ng/ml) (for B. pertussis, forward 5′-GACTTCGTCTTC-GTGGCCAT-3′, reverse 5′-GTACAGCGCGCC-CGATGCCT-3′; for B. parapertussis, forward 5′-CGCCGCTTGATGACCTTGATA-3′, reverse 5′-CACCGCCTACGAGTTGGAGAT-3′), 0.4 ml of Taq polymerase (5 U/µl) and 18.6 ml of water. DNA amplification was performed as follows: initial denaturation at 94°C for 2 min, followed by 20 cycles of 94°C for 30 s, 57°C for 30 s and 72°C for 30 s, and final extension at 72°C for 5 min.
After the first amplification, 5 µl of the amplified product was added to 5 µl of PCR buffer × 10 (without MgCl 2 ), 2.7µl of 25 mM MgCl 2 , 1.8 l of 5 mM dNTP mix, 1µl of each of the two inner primers (100 ng/µl) (for B. pertussis, forward 5′-CGCGTGGCCTTCAC-CGACAT-3′, reverse 5′-GGGCGGTAAGGTCG-GGTAAA-3′; for B. parapertussis, forward 5′-CGCTGGCTGCTGCTGCGCAA-3′, reverse 5′-GTGGTTCCAGGCTTGTCTTG-3′), 0.4 ml of Taq polymerase (5 U/ml) and 28.1 ml of water. A second amplification was then performed as follows: initial denaturation at 94°C for 2 min, followed by 30 cycles of 94°C for 30 s, 57°C for 30 s and 72°C for 30 s, and final extension at 72°C for 5 min. Values are mean ± SD.
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In order to assess test specificity, the same amplification protocol was used on 35 samples previously confirmed positive for influenza or respiratory syncytial virus (RSV).
GEL ELECTROPHORESIS
After PCR amplification, electrophoretic separation of the DNA samples was performed on agarose gel. A band at 205 and 171 bp for B. pertussis and B. parapertussis, respectively, verifiable by direct comparison with the molecular weight bands, indicated the presence of the bacterial genome. Water and colorant were used as negative controls. Low molecular weight bands, if present, would consist of dimers formed by loose primers and have no relevance to the interpretation of results.
Results
CULTURE
Positive cultures were characterized by the presence of small, shiny, greyish-white, round convex colonies for B. pertussis, whereas the colonies of B. parapertussis were slightly bigger and less shiny than those of B. pertussis.
The number of bacterial colonies on the plates decreased as the dilution increased; bacterial growth could no longer be seen from a dilution of 10 -8 for both B. pertussis (Table 1 ) and B. parapertussis (Table 2) .
DNA EXTRACTION
DNA extraction was performed on bacterial suspensions in sterile physiological solution or sterile distilled water of B. pertussis and B. parapertussis and their respective serial dilutions. Spectrophotometric evaluation showed that the yield and purity of the DNA extract were high from bacterial cells suspended in sterile distilled water, in contrast to the low yield and purity from bacterial cells suspended in sterile physiological saline.
NESTED POLYMERASE CHAIN REACTION AND GEL ELECTROPHORESIS
In the light of the DNA extraction results, only the extracts of the bacterial suspensions in sterile distilled water and their dilutions were used for the DNA amplification.
Amplification of bacterial DNA showed positive results up to a dilution of 10 -8 of the initial suspension for B. pertussis (Table 1 ) and up to a dilution of 10 -9 for B. parapertussis ( Table 2) PCR and culture for detection of B. pertussis and B. parapertussis by culture and PCR showed that the results were 80% similar, PCR providing higher analytical sensitivity than that obtained by culture.
No amplification band was seen when the PCR was performed with the water and colorant-negative controls, indicating that the test had been performed correctly. None of the samples positive for RSV or influenza virus was positive on PCR for B. pertussis or B. parapertussis.
Discussion
Pertussis is a highly contagious disease and can last for months. The paroxysmal stage is characterized by coughing attacks frequently accompanied by apnoea and cyanosis, and by a characteristic whoop due to inspiratory effort through the narrowed glottis after a burst of coughing. 7 Worldwide, pertussis is still a major cause of childhood mortality and disability, with approximately 300 000 deaths and 50 000 cases of long-term pertussis-associated neurological complications occurring each year. 3 The age group most affected is those aged 0 -5 years; newborns are particularly susceptible, presumably as a consequence of the low titre of antibodies present in maternal blood. 8 Following the introduction of the vaccine in Italy, the incidence of pertussis and pertussis-related complications and mortality during the first year of life and in pre-school children has decreased, falling to less than 2000 cases per year since 1999 as a result of increased vaccination coverage (national average > 95%). 9, 10 The immunity conferred by pertussis vaccine or infection is not permanent, as evidenced by the number of cases among adolescents and adults in countries with high vaccination coverage rates. On the one hand, high vaccination coverage reduces the incidence of pertussis in children, but on the other hand, it also reduces the availability of natural boosters.
Paroxysmal attacks in children are a typical feature of pertussis and the diagnosis can generally be made clinically. However, atypical cases can occur, particularly during the first year of life, in adolescents/adults and in vaccinated subjects. In addition, other illnesses can produce a clinical picture similar to pertussis in children, including asthma, RSV, adenovirus, Mycoplasma pneumoniae and PCR and culture for detection of B. pertussis and B. parapertussis occasionally Chlamydia pneumoniae. In such cases, diagnosis based on a clinical definition may lead to false-positive results. 11 In view of this, and as vaccination coverage and infection control increase, it is increasingly important that the diagnosis is confirmed by laboratory tests in order to obtain accurate information about the incidence of pertussis and the efficacy of vaccination strategies.
Culture isolation is the standard test for the identification of B. pertussis. It is very specific but its sensitivity depends on several factors, including sampling method, age and immunity status of the patient, and stage of illness. As a result, culture sensitivity is low even under optimal technical conditions, particularly in atypical pertussis cases. 12, 13 In recent years, molecular biology methods such as PCR have been developed as an alternative for the diagnosis of several infectious diseases, in particular those caused by unculturable organisms. 14 PCR has also been used to diagnose pertussis; however, due to differences in the choice of target genes, amplification primers and method, an operational protocol has not yet been universally accepted. 11, 14 The regions most frequently used for DNA amplification within a clinical setting are the sequence in the PT promoter region and the insertion sequences IS481 and IS1001 for B. pertussis and B. parapertussis, respectively. 15 PCR seems to be a rapid, sensitive and specific method; its positivity can be seen more than 14 days after the beginning of antibiotic therapy.
In the present study we evaluated the performance of genomic DNA amplification by PCR, targeting the insertion sequences IS481 and IS1001. The results confirmed that, under the same initial conditions, PCR is more sensitive than culture for the species B. pertussis and B. parapertussis.
In Italy, there is a paucity of data on B. pertussis incidence rates in children aged < 1 year, in adolescents and in adults. It is therefore important to evaluate the presence of B. pertussis in the general population and compare it with an analysis of the notifications and vaccination coverage rates reached in different geographical areas. It would be valuable to study the epidemiology of B. pertussis and B. parapertussis in specific age groups, such as children aged < 1 year (as they have not yet completed the primary vaccination cycle and are at risk of developing serious, often fatal, complications) and adolescents/adults, as pertussis is difficult to diagnose in these subjects. Since culture isolation, regarded as an effective identification method, is most successful during the first stage of pertussis and its efficacy declines considerably (to below 60%) after this period or with prior vaccination or antibiotic therapy, PCR, although not yet standardized, may provide an innovative alternative diagnostic tool. 11, 16 
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